Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Nature Communications
|
August 4, 2023
Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria
Judith U Oguzie, Brittany A Petros, Paul E Oluniyi, et al.
Nature Communications
|
August 19, 2020
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
Kayla G Barnes, Anna E Lachenauer, Adam Nitido, et al.
Scientific Reports
|
April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
Matthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Viruses
|
November 26, 2014
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014
Jens H Kuhn, Kristian G Andersen, Sylvain Baize, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans
Edyth Parker, Ifeanyi F Omah, Patrick Varilly, et al.
Scientific Reports
|
May 28, 2020
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
Matthew L Boisen, Eghosa Uyigue, John Aiyepada, et al.
Nature Biotechnology
|
February 6, 2019
Capturing sequence diversity in metagenomes with comprehensive and scalable probe design
Hayden C Metsky, Katherine J Siddle, Adrianne Gladden-Young, et al.
Scientific Reports
|
September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
Megan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.
The New England Journal of Medicine
|
October 18, 2018
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
Katherine J Siddle, Philomena Eromon, Kayla G Barnes, et al.
Nature Communications
|
May 11, 2016
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E Robinson, Kathryn M Hastie, Robert W Cross, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Nature Communications
|
August 4, 2023
Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria
Judith U Oguzie, Brittany A Petros, Paul E Oluniyi, et al.
Nature Communications
|
August 19, 2020
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
Kayla G Barnes, Anna E Lachenauer, Adam Nitido, et al.
Scientific Reports
|
April 14, 2018
Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
Matthew L Boisen, Jessica N Hartnett, Jeffrey G Shaffer, et al.
Viruses
|
November 26, 2014
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014
Jens H Kuhn, Kristian G Andersen, Sylvain Baize, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans
Edyth Parker, Ifeanyi F Omah, Patrick Varilly, et al.
Scientific Reports
|
May 28, 2020
Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
Matthew L Boisen, Eghosa Uyigue, John Aiyepada, et al.
Nature Biotechnology
|
February 6, 2019
Capturing sequence diversity in metagenomes with comprehensive and scalable probe design
Hayden C Metsky, Katherine J Siddle, Adrianne Gladden-Young, et al.
Scientific Reports
|
September 30, 2020
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
Megan L Heinrich, Matthew L Boisen, Diana K S Nelson, et al.
The New England Journal of Medicine
|
October 18, 2018
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
Katherine J Siddle, Philomena Eromon, Kayla G Barnes, et al.
Nature Communications
|
May 11, 2016
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E Robinson, Kathryn M Hastie, Robert W Cross, et al.
Page
of 11